Allspring Global Investments
STRO icon

Allspring Global Investments’s Sutro Biopharma STRO Stock Holding History

Allspring Global Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$51 – 2348
2024
Q3 		$51 Buy
+2
New +$78 ﹤0.01% 2437
2023
Q4 		– Sell
-1,732
Closed -$60.1K – 2708
2023
Q3 		$60.1K Sell
1,732
-91
-5% -$3.96K ﹤0.01% 2201
2023
Q2 		$84.8K Sell
1,823
-568
-24% -$28.3K ﹤0.01% 2119
2023
Q1 		$110K Sell
2,391
-677
-22% -$43K ﹤0.01% 2016
2022
Q4 		$248K Buy
3,068
+2,140
+231% +$149K ﹤0.01% 1777
2022
Q3 		$51K Buy
+928
New +$54.9K ﹤0.01% 2352
2022
Q2 		– Sell
-3,132
Closed -$257K – 2919
2022
Q1 		$257K Sell
3,132
-358
-10% -$34.1K ﹤0.01% 2488
2021
Q4 		$519K Buy
+3,490
New +$625K ﹤0.01% 2275

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Allspring Global Investments's STRO Position: Q4 2024 in Review

Allspring Global Investments sold out of Sutro Biopharma (STRO) in Q4 2024, closing a stake of 2 shares — an estimated $51 sold.

Allspring Global Investments first reported a position in STRO in Q4 2021 and held it in 8 quarters. The position peaked at $519K in Q4 2021. 122 funds tracked by Wall St. Rank hold STRO as of Q4 2024.

  • Allspring Global Investments reported no remaining Sutro Biopharma position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 2 Sutro Biopharma shares in Q4 2024, an estimated $51.
  • Allspring Global Investments first reported a position in Sutro Biopharma in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Sutro Biopharma position peaked at $519K in Q4 2021.
  • 122 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.